CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 198 filers reported holding CHEMOCENTRYX INC in Q2 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $584,000 | -58.8% | 11,400 | -50.2% | 0.00% | -50.0% |
| Q4 2020 | $1,417,000 | +31.3% | 22,885 | +16.2% | 0.01% | +20.0% |
| Q3 2020 | $1,079,000 | +20.7% | 19,695 | +26.8% | 0.01% | +25.0% |
| Q2 2020 | $894,000 | +41.9% | 15,535 | -1.0% | 0.00% | 0.0% |
| Q1 2020 | $630,000 | +4.7% | 15,685 | +3.1% | 0.00% | +33.3% |
| Q4 2019 | $602,000 | +173.6% | 15,215 | -35.8% | 0.00% | +200.0% |
| Q2 2019 | $220,000 | -27.2% | 23,692 | +8.8% | 0.00% | -50.0% |
| Q1 2019 | $302,000 | +45.2% | 21,772 | +14.4% | 0.00% | +100.0% |
| Q4 2018 | $208,000 | -31.4% | 19,032 | -20.5% | 0.00% | -50.0% |
| Q3 2018 | $303,000 | -3.8% | 23,932 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $315,000 | -41.7% | 23,932 | -73.6% | 0.00% | -33.3% |
| Q4 2017 | $540,000 | +30.4% | 90,684 | +62.6% | 0.00% | +50.0% |
| Q3 2017 | $414,000 | – | 55,780 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |